Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 291

1.

Underuse of exon mutational analysis for gastrointestinal stromal tumors.

Bartholomew AJ, Dohnalek H, Prins PA, O'Neill SC, Quadri HS, Marshall JL, Haddad NG, Al-Refaie WB.

J Surg Res. 2018 Nov;231:43-48. doi: 10.1016/j.jss.2018.05.014. Epub 2018 Jun 7.

PMID:
30278964
2.

Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B trials in the ARCAD database.

Salem ME, Yin J, Weinberg BA, Renfro LA, Pederson LD, Maughan TS, Adams RA, Van Cutsem E, Falcone A, Tebbutt NC, Seymour MT, Díaz-Rubio E, Aranda E, Bokemeyer C, Heinemann V, Wasan H, de Gramont A, Grothey A, Shi Q, Sargent DJ, Marshall JL.

Eur J Cancer. 2018 Sep 27;103:205-213. doi: 10.1016/j.ejca.2018.08.020. [Epub ahead of print]

PMID:
30268921
3.

Prevalence of Homologous Recombination-Related Gene Mutations Across Multiple Cancer Types.

Heeke AL, Pishvaian MJ, Lynce F, Xiu J, Brody JR, Chen WJ, Baker TM, Marshall JL, Isaacs C.

JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.17.00286. Epub 2018 Jul 23.

4.

Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United States.

Kim S, Signorovitch JE, Yang H, Patterson-Lomba O, Xiang CQ, Ung B, Parisi M, Marshall JL.

Adv Ther. 2018 Sep 12. doi: 10.1007/s12325-018-0784-z. [Epub ahead of print]

PMID:
30209750
5.

Impact of Patient Age on Molecular Alterations of Left-Sided Colorectal Tumors.

Puccini A, Lenz HJ, Marshall JL, Arguello D, Raghavan D, Korn WM, Weinberg BA, Poorman K, Heeke AL, Philip PA, Shields AF, Goldberg RM, Salem ME.

Oncologist. 2018 Jul 17. pii: theoncologist.2018-0117. doi: 10.1634/theoncologist.2018-0117. [Epub ahead of print]

PMID:
30018131
6.

Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.

Salem ME, Puccini A, Xiu J, Raghavan D, Lenz HJ, Korn WM, Shields AF, Philip PA, Marshall JL, Goldberg RM.

Oncologist. 2018 Jun 4. pii: theoncologist.2018-0143. doi: 10.1634/theoncologist.2018-0143. [Epub ahead of print]

PMID:
29866946
7.

Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease.

Boyiadzis MM, Kirkwood JM, Marshall JL, Pritchard CC, Azad NS, Gulley JL.

J Immunother Cancer. 2018 May 14;6(1):35. doi: 10.1186/s40425-018-0342-x.

8.

Immuno-Oncology Biomarkers for Gastric and Gastroesophageal Junction Adenocarcinoma: Why PD-L1 Testing May Not Be Enough.

Weinberg BA, Xiu J, Hwang JJ, Shields AF, Salem ME, Marshall JL.

Oncologist. 2018 Oct;23(10):1171-1177. doi: 10.1634/theoncologist.2018-0034. Epub 2018 Apr 27.

PMID:
29703766
9.

Congenital Titinopathy: Comprehensive characterization and pathogenic insights.

Oates EC, Jones KJ, Donkervoort S, Charlton A, Brammah S, Smith JE 3rd, Ware JS, Yau KS, Swanson LC, Whiffin N, Peduto AJ, Bournazos A, Waddell LB, Farrar MA, Sampaio HA, Teoh HL, Lamont PJ, Mowat D, Fitzsimons RB, Corbett AJ, Ryan MM, O'Grady GL, Sandaradura SA, Ghaoui R, Joshi H, Marshall JL, Nolan MA, Kaur S, Punetha J, Töpf A, Harris E, Bakshi M, Genetti CA, Marttila M, Werlauff U, Streichenberger N, Pestronk A, Mazanti I, Pinner JR, Vuillerot C, Grosmann C, Camacho A, Mohassel P, Leach ME, Foley AR, Bharucha-Goebel D, Collins J, Connolly AM, Gilbreath HR, Iannaccone ST, Castro D, Cummings BB, Webster RI, Lazaro L, Vissing J, Coppens S, Deconinck N, Luk HM, Thomas NH, Foulds NC, Illingworth MA, Ellard S, McLean CA, Phadke R, Ravenscroft G, Witting N, Hackman P, Richard I, Cooper ST, Kamsteeg EJ, Hoffman EP, Bushby K, Straub V, Udd B, Ferreiro A, North KN, Clarke NF, Lek M, Beggs AH, Bönnemann CG, MacArthur DG, Granzier H, Davis MR, Laing NG.

Ann Neurol. 2018 Jun;83(6):1105-1124. doi: 10.1002/ana.25241.

PMID:
29691892
10.

A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer.

Pishvaian MJ, Slack RS, Jiang W, He AR, Hwang JJ, Hankin A, Dorsch-Vogel K, Kukadiya D, Weiner LM, Marshall JL, Brody JR.

Cancer. 2018 Jun 1;124(11):2337-2346. doi: 10.1002/cncr.31309. Epub 2018 Mar 26.

PMID:
29579325
11.

Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes.

Domenyuk V, Gatalica Z, Santhanam R, Wei X, Stark A, Kennedy P, Toussaint B, Levenberg S, Wang J, Xiao N, Greil R, Rinnerthaler G, Gampenrieder SP, Heimberger AB, Berry DA, Barker A, Quackenbush J, Marshall JL, Poste G, Vacirca JL, Vidal GA, Schwartzberg LS, Halbert DD, Voss A, Magee D, Miglarese MR, Famulok M, Mayer G, Spetzler D.

Nat Commun. 2018 Mar 23;9(1):1219. doi: 10.1038/s41467-018-03631-z.

12.

Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers.

Salem ME, Puccini A, Grothey A, Raghavan D, Goldberg RM, Xiu J, Korn WM, Weinberg BA, Hwang JJ, Shields AF, Marshall JL, Philip PA, Lenz HJ.

Mol Cancer Res. 2018 May;16(5):805-812. doi: 10.1158/1541-7786.MCR-17-0735. Epub 2018 Mar 9.

PMID:
29523759
13.

Corrigendum: Landscape of X chromosome inactivation across human tissues.

Tukiainen T, Villani AC, Yen A, Rivas MA, Marshall JL, Satija R, Aguirre M, Gauthier L, Fleharty M, Kirby A, Cummings BB, Castel SE, Karczewski KJ, Aguet F, Byrnes A, Consortium G, Lappalainen T, Regev A, Ardlie KG, Hacohen N, MacArthur DG.

Nature. 2018 Mar 7;555(7695):274. doi: 10.1038/nature25993.

PMID:
29517003
14.

Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis.

Mizoguchi F, Slowikowski K, Wei K, Marshall JL, Rao DA, Chang SK, Nguyen HN, Noss EH, Turner JD, Earp BE, Blazar PE, Wright J, Simmons BP, Donlin LT, Kalliolias GD, Goodman SM, Bykerk VP, Ivashkiv LB, Lederer JA, Hacohen N, Nigrovic PA, Filer A, Buckley CD, Raychaudhuri S, Brenner MB.

Nat Commun. 2018 Feb 23;9(1):789. doi: 10.1038/s41467-018-02892-y.

15.

A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies.

Deeken JF, Wang H, Hartley M, Cheema AK, Smaglo B, Hwang JJ, He AR, Weiner LM, Marshall JL, Giaccone G, Liu S, Luecht J, Spiegel JY, Pishvaian MJ.

Cancer Chemother Pharmacol. 2018 Mar;81(3):587-596. doi: 10.1007/s00280-018-3533-8. Epub 2018 Feb 1.

PMID:
29392450
16.

CD103+CD11b+ mucosal classical dendritic cells initiate long-term switched antibody responses to flagellin.

Flores-Langarica A, Müller Luda K, Persson EK, Cook CN, Bobat S, Marshall JL, Dahlgren MW, Hägerbrand K, Toellner KM, Goodall MD, Withers DR, Henderson IR, Johansson Lindbom B, Cunningham AF, Agace WW.

Mucosal Immunol. 2018 May;11(3):681-692. doi: 10.1038/mi.2017.105. Epub 2017 Dec 20.

PMID:
29346347
17.

Deciding the Duration of Adjuvant Chemotherapy in a Patient With Stage III Colon Cancer: When Can Less Be More?

Trivedi ND, Marshall JL.

Oncology (Williston Park). 2017 Dec 15;31(12):863-5, 871, 884. No abstract available.

18.

Molecular characteristics of hepatocellular carcinomas from different age groups.

Ang C, Shields A, Xiu J, Gatalica Z, Reddy S, Salem ME, Farhangfar C, Hwang J, Astsaturov I, Marshall JL.

Oncotarget. 2017 Sep 27;8(60):101591-101598. doi: 10.18632/oncotarget.21353. eCollection 2017 Nov 24.

19.

"It's like rotations, but in the classroom": Creation of an innovative course to prepare students for advanced pharmacy practice experiences.

Hardy YM, Marshall JL.

Curr Pharm Teach Learn. 2017 Nov;9(6):1129-1140. doi: 10.1016/j.cptl.2017.07.009. Epub 2017 Aug 23.

PMID:
29233382
20.

Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers.

Salem ME, Weinberg BA, Xiu J, El-Deiry WS, Hwang JJ, Gatalica Z, Philip PA, Shields AF, Lenz HJ, Marshall JL.

Oncotarget. 2017 Sep 21;8(49):86356-86368. doi: 10.18632/oncotarget.21169. eCollection 2017 Oct 17.

21.

Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer.

Vietsch EE, Graham GT, McCutcheon JN, Javaid A, Giaccone G, Marshall JL, Wellstein A.

Cancer Genet. 2017 Dec;218-219:39-50. doi: 10.1016/j.cancergen.2017.08.006. Epub 2017 Sep 14.

PMID:
29153095
22.

A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal Cancer.

Grothey A, Strosberg JR, Renfro LA, Hurwitz HI, Marshall JL, Safran H, Guarino MJ, Kim GP, Hecht JR, Weil SC, Heyburn J, Wang W, Schweizer C, O'Shannessy DJ, Diaz LA Jr.

Clin Cancer Res. 2018 Jan 15;24(2):316-325. doi: 10.1158/1078-0432.CCR-17-1558. Epub 2017 Oct 30.

PMID:
29084918
23.

Light curves of the neutron star merger GW170817/SSS17a: Implications for r-process nucleosynthesis.

Drout MR, Piro AL, Shappee BJ, Kilpatrick CD, Simon JD, Contreras C, Coulter DA, Foley RJ, Siebert MR, Morrell N, Boutsia K, Di Mille F, Holoien TW, Kasen D, Kollmeier JA, Madore BF, Monson AJ, Murguia-Berthier A, Pan YC, Prochaska JX, Ramirez-Ruiz E, Rest A, Adams C, Alatalo K, Bañados E, Baughman J, Beers TC, Bernstein RA, Bitsakis T, Campillay A, Hansen TT, Higgs CR, Ji AP, Maravelias G, Marshall JL, Bidin CM, Prieto JL, Rasmussen KC, Rojas-Bravo C, Strom AL, Ulloa N, Vargas-González J, Wan Z, Whitten DD.

Science. 2017 Dec 22;358(6370):1570-1574. doi: 10.1126/science.aaq0049. Epub 2017 Oct 16.

PMID:
29038375
24.

Early spectra of the gravitational wave source GW170817: Evolution of a neutron star merger.

Shappee BJ, Simon JD, Drout MR, Piro AL, Morrell N, Prieto JL, Kasen D, Holoien TW, Kollmeier JA, Kelson DD, Coulter DA, Foley RJ, Kilpatrick CD, Siebert MR, Madore BF, Murguia-Berthier A, Pan YC, Prochaska JX, Ramirez-Ruiz E, Rest A, Adams C, Alatalo K, Bañados E, Baughman J, Bernstein RA, Bitsakis T, Boutsia K, Bravo JR, Di Mille F, Higgs CR, Ji AP, Maravelias G, Marshall JL, Placco VM, Prieto G, Wan Z.

Science. 2017 Dec 22;358(6370):1574-1578. doi: 10.1126/science.aaq0186. Epub 2017 Oct 16.

PMID:
29038374
25.

Landscape of X chromosome inactivation across human tissues.

Tukiainen T, Villani AC, Yen A, Rivas MA, Marshall JL, Satija R, Aguirre M, Gauthier L, Fleharty M, Kirby A, Cummings BB, Castel SE, Karczewski KJ, Aguet F, Byrnes A; GTEx Consortium; Laboratory, Data Analysis &Coordinating Center (LDACC)—Analysis Working Group; Statistical Methods groups—Analysis Working Group; Enhancing GTEx (eGTEx) groups; NIH Common Fund; NIH/NCI; NIH/NHGRI; NIH/NIMH; NIH/NIDA; Biospecimen Collection Source Site—NDRI; Biospecimen Collection Source Site—RPCI; Biospecimen Core Resource—VARI; Brain Bank Repository—University of Miami Brain Endowment Bank; Leidos Biomedical—Project Management; ELSI Study; Genome Browser Data Integration &Visualization—EBI; Genome Browser Data Integration &Visualization—UCSC Genomics Institute, University of California Santa Cruz, Lappalainen T, Regev A, Ardlie KG, Hacohen N, MacArthur DG.

Nature. 2017 Oct 11;550(7675):244-248. doi: 10.1038/nature24265. Erratum in: Nature. 2018 Mar 7;555(7695):274.

26.

Synthesis of the Unknown Indeno[1,2-a]fluorene Regioisomer: Crystallographic Characterization of Its Dianion.

Dressler JJ, Zhou Z, Marshall JL, Kishi R, Takamuku S, Wei Z, Spisak SN, Nakano M, Petrukhina MA, Haley MM.

Angew Chem Int Ed Engl. 2017 Nov 27;56(48):15363-15367. doi: 10.1002/anie.201709282. Epub 2017 Oct 24.

PMID:
28985444
27.

Phase I/II Trial of Labetuzumab Govitecan (Anti-CEACAM5/SN-38 Antibody-Drug Conjugate) in Patients With Refractory or Relapsing Metastatic Colorectal Cancer.

Dotan E, Cohen SJ, Starodub AN, Lieu CH, Messersmith WA, Simpson PS, Guarino MJ, Marshall JL, Goldberg RM, Hecht JR, Wegener WA, Sharkey RM, Govindan SV, Goldenberg DM, Berlin JD.

J Clin Oncol. 2017 Oct 10;35(29):3338-3346. doi: 10.1200/JCO.2017.73.9011. Epub 2017 Aug 17.

PMID:
28817371
28.

Stromal cell markers are differentially expressed in the synovial tissue of patients with early arthritis.

Choi IY, Karpus ON, Turner JD, Hardie D, Marshall JL, de Hair MJH, Maijer KI, Tak PP, Raza K, Hamann J, Buckley CD, Gerlag DM, Filer A.

PLoS One. 2017 Aug 9;12(8):e0182751. doi: 10.1371/journal.pone.0182751. eCollection 2017.

29.

Expanded Indacene-Tetrathiafulvalene Scaffolds: Structural Implications for Redox Properties and Association Behavior.

Petersen JF, Frederickson CK, Marshall JL, Rudebusch GE, Zakharov LN, Hammerich O, Haley MM, Nielsen MB.

Chemistry. 2017 Sep 21;23(53):13120-13130. doi: 10.1002/chem.201702347. Epub 2017 Aug 23.

PMID:
28696021
30.

A giant planet undergoing extreme-ultraviolet irradiation by its hot massive-star host.

Gaudi BS, Stassun KG, Collins KA, Beatty TG, Zhou G, Latham DW, Bieryla A, Eastman JD, Siverd RJ, Crepp JR, Gonzales EJ, Stevens DJ, Buchhave LA, Pepper J, Johnson MC, Colon KD, Jensen ELN, Rodriguez JE, Bozza V, Novati SC, D'Ago G, Dumont MT, Ellis T, Gaillard C, Jang-Condell H, Kasper DH, Fukui A, Gregorio J, Ito A, Kielkopf JF, Manner M, Matt K, Narita N, Oberst TE, Reed PA, Scarpetta G, Stephens DC, Yeigh RR, Zambelli R, Fulton BJ, Howard AW, James DJ, Penny M, Bayliss D, Curtis IA, DePoy DL, Esquerdo GA, Gould A, Joner MD, Kuhn RB, Labadie-Bartz J, Lund MB, Marshall JL, McLeod KK, Pogge RW, Relles H, Stockdale C, Tan TG, Trueblood M, Trueblood P.

Nature. 2017 Jun 22;546(7659):514-518. doi: 10.1038/nature22392. Epub 2017 Jun 5.

PMID:
28582774
31.

The Growing Challenge of Young Adults With Colorectal Cancer.

Weinberg BA, Marshall JL, Salem ME.

Oncology (Williston Park). 2017 May 15;31(5):381-9. Review.

32.

Improving genetic diagnosis in Mendelian disease with transcriptome sequencing.

Cummings BB, Marshall JL, Tukiainen T, Lek M, Donkervoort S, Foley AR, Bolduc V, Waddell LB, Sandaradura SA, O'Grady GL, Estrella E, Reddy HM, Zhao F, Weisburd B, Karczewski KJ, O'Donnell-Luria AH, Birnbaum D, Sarkozy A, Hu Y, Gonorazky H, Claeys K, Joshi H, Bournazos A, Oates EC, Ghaoui R, Davis MR, Laing NG, Topf A; Genotype-Tissue Expression Consortium, Kang PB, Beggs AH, North KN, Straub V, Dowling JJ, Muntoni F, Clarke NF, Cooper ST, Bönnemann CG, MacArthur DG.

Sci Transl Med. 2017 Apr 19;9(386). pii: eaal5209. doi: 10.1126/scitranslmed.aal5209.

33.

Molecular Testing to Optimize and Personalize Decision Making in the Management of Colorectal Cancer.

Al-Hajeili M, Shields AF, Hwang JJ, Wadlow RC, Marshall JL.

Oncology (Williston Park). 2017 Apr 15;31(4):301-12. Review.

34.

Alternative Visions for Pastoral Work with LGBTQ Individuals, Families, and Communities: A Response.

Marshall JL.

J Pastoral Care Counsel. 2017 Mar;71(1):60-68. doi: 10.1177/1542305017693637.

PMID:
28279140
35.

Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis.

Rao DA, Gurish MF, Marshall JL, Slowikowski K, Fonseka CY, Liu Y, Donlin LT, Henderson LA, Wei K, Mizoguchi F, Teslovich NC, Weinblatt ME, Massarotti EM, Coblyn JS, Helfgott SM, Lee YC, Todd DJ, Bykerk VP, Goodman SM, Pernis AB, Ivashkiv LB, Karlson EW, Nigrovic PA, Filer A, Buckley CD, Lederer JA, Raychaudhuri S, Brenner MB.

Nature. 2017 Feb 1;542(7639):110-114. doi: 10.1038/nature20810.

36.

Indacenodibenzothiophenes: synthesis, optoelectronic properties and materials applications of molecules with strong antiaromatic character.

Marshall JL, Uchida K, Frederickson CK, Schütt C, Zeidell AM, Goetz KP, Finn TW, Jarolimek K, Zakharov LN, Risko C, Herges R, Jurchescu OD, Haley MM.

Chem Sci. 2016;7(8):5547-5558. doi: 10.1039/C6SC00950F. Epub 2016 May 13.

37.

Quantification and expert evaluation of evidence for chemopredictive biomarkers to personalize cancer treatment.

Rao S, Beckman RA, Riazi S, Yabar CS, Boca SM, Marshall JL, Pishvaian MJ, Brody JR, Madhavan S.

Oncotarget. 2017 Jun 6;8(23):37923-37934. doi: 10.18632/oncotarget.13544. Review.

38.

Rheumatoid synovial fibroblasts differentiate into distinct subsets in the presence of cytokines and cartilage.

Croft AP, Naylor AJ, Marshall JL, Hardie DL, Zimmermann B, Turner J, Desanti G, Adams H, Yemm AI, Müller-Ladner U, Dayer JM, Neumann E, Filer A, Buckley CD.

Arthritis Res Ther. 2016 Nov 18;18(1):270.

39.

High levels of sarcospan are well tolerated and act as a sarcolemmal stabilizer to address skeletal muscle and pulmonary dysfunction in DMD.

Gibbs EM, Marshall JL, Ma E, Nguyen TM, Hong G, Lam JS, Spencer MJ, Crosbie-Watson RH.

Hum Mol Genet. 2016 Dec 15;25(24):5395-5406. doi: 10.1093/hmg/ddw356.

40.

Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases PDE5A and PDE9A.

Alexander MS, Gasperini MJ, Tsai PT, Gibbs DE, Spinazzola JM, Marshall JL, Feyder MJ, Pletcher MT, Chekler EL, Morris CA, Sahin M, Harms JF, Schmidt CJ, Kleiman RJ, Kunkel LM.

Transl Psychiatry. 2016 Sep 27;6(9):e901. doi: 10.1038/tp.2016.174.

41.

Trifluridine/tipiracil and regorafenib: new weapons in the war against metastatic colorectal cancer.

Weinberg BA, Marshall JL, Salem ME.

Clin Adv Hematol Oncol. 2016 Aug;14(8):630-8. Review.

PMID:
27487107
42.

Diindeno-fusion of an anthracene as a design strategy for stable organic biradicals.

Rudebusch GE, Zafra JL, Jorner K, Fukuda K, Marshall JL, Arrechea-Marcos I, Espejo GL, Ponce Ortiz R, Gómez-García CJ, Zakharov LN, Nakano M, Ottosson H, Casado J, Haley MM.

Nat Chem. 2016 Aug;8(8):753-9. doi: 10.1038/nchem.2518. Epub 2016 May 23.

PMID:
27442280
43.

Neoadjuvant Combined-Modality Therapy for Locally Advanced Rectal Cancer and Its Future Direction.

Salem ME, Hartley M, Unger K, Marshall JL.

Oncology (Williston Park). 2016 Jun;30(6):546-62. Review.

44.

Differentiation-related glycan epitopes identify discrete domains of the muscle glycocalyx.

McMorran BJ, McCarthy FE, Gibbs EM, Pang M, Marshall JL, Nairn AV, Moremen KW, Crosbie-Watson RH, Baum LG.

Glycobiology. 2016 Oct;26(10):1120-1132. doi: 10.1093/glycob/cww061. Epub 2016 May 28.

45.

Approach to the medical management of surgically resectable gastric cancer.

Tesfaye A, Marshall JL, Smaglo BG.

Clin Adv Hematol Oncol. 2016 Feb;14(2):129-35. Review.

PMID:
27057811
46.

A paradigm shift from one-size-fits-all to tailor-made therapy for metastatic colorectal cancer.

Weinberg BA, Marshall JL, Hartley M, Salem ME.

Clin Adv Hematol Oncol. 2016 Feb;14(2):116-28. Review.

PMID:
27057810
47.

Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma.

Noonan AM, Farren MR, Geyer SM, Huang Y, Tahiri S, Ahn D, Mikhail S, Ciombor KK, Pant S, Aparo S, Sexton J, Marshall JL, Mace TA, Wu CS, El-Rayes B, Timmers CD, Zwiebel J, Lesinski GB, Villalona-Calero MA, Bekaii-Saab TS.

Mol Ther. 2016 Jun;24(6):1150-1158. doi: 10.1038/mt.2016.66. Epub 2016 Apr 4.

48.

Patients Living Longer With Metastatic Colorectal Cancer.

Marshall JL, Sommers R.

J Adv Pract Oncol. 2016 Apr;7(3):286-288. Epub 2016 Apr 1. Review. No abstract available.

49.

Synthesis and Characterization of Two Unsymmetrical Indenofluorene Analogues: Benzo[5,6]-s-indaceno[1,2-b]thiophene and Benzo[5,6]-s-indaceno[2,1-b]thiophene.

Marshall JL, O'Neal NJ, Zakharov LN, Haley MM.

J Org Chem. 2016 May 6;81(9):3674-80. doi: 10.1021/acs.joc.6b00340. Epub 2016 Apr 8.

PMID:
27014864
50.

Current Options for Third-Line Treatment of Metastatic Colorectal Cancer.

Grothey A, Marshall JL, Seery TE.

Clin Adv Hematol Oncol. 2016 Mar;14(3 Suppl 3):1-15.

PMID:
27007241

Supplemental Content

Loading ...
Support Center